Shanghai Kaibao Pharmaceutical Co.,Ltd.’s Net Profit Rose 40.2% in First Quarter of 2023

Shanghai Kaibao Pharmaceutical Co.,Ltd. (上海凯宝药业股份有限公司) (300039.SZ) reported a net profit of 80.1 million yuan in the first quarter of 2023, up 40.2% year-on-year.

Meanwhile, the company posted 459.4 million yuan in revenue, up 33.6% year-on-year.

At the end of the reporting period, it had 4.8 billion yuan in total assets and 642.8 million yuan in total liabilities, with a liability-to-asset ratio of 13.5%.